MarginsXMarginsX
Home › Markets › Health Care › FRNM

Freenome Inc. (FRNM)

FRNM trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$10.09
-3.07% on the day
Market cap
$1.1B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerFRNM on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0002017526
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
Cash-flow positive
$180.4M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$180.4M cash; operating cash flow $20.5M a quarter.Report 2026-09-30
Shares outstanding111,500,956 (2026-11-09).Cover page 2026-11-09
Reverse splits, 3 years1; latest on 2026-07-24Source 2026-07-24
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-07-20
AuditorWithumSmith+Brown, PC, New York, New York, United States; changed auditors 1 time in 24 months8-K 4.01 2026-07-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$183.5M$60.1M-$58.3M$180.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$69.0M-$130K$437KNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$63.6M-$298K$567KNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed$181.9M$140.8M$78.6MNo debt tagsNeeds four quarters10-K 2026-03-12
Q3 2025
2025-09-30
$1.0M-$64.5M-$141.3M$74.0MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$58.7M-$148K$1.3MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$57.9M-$238K$1.2MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
Not filed$841K-$80K$76.2MNo debt tagsNeeds four quarters10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-13
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-10
Latest proxy
DEF14A
DEF 14A2026-05-14

Source: SEC EDGAR submissions feed, 143 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.3%
1 month-17.6%
3 months-10.3%
Year to date-20.1%
1 year-3.5%
From 52-week high-39.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
CSTLCastle Biosciences Inc.$32.75-3.08%$1.0B
LMRILumexa Imaging Holdings Inc.$14.79-0.14%$1.4B
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
TRUPTrupanion Inc.$36.16+4.87%$1.6B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
FLGTFulgent Genetics Inc.$24.07-2.37%$672.6M
FTREFortrea Holdings Inc.$19.79-2.03%$1.9B
VCYTVeracyte Inc.$24.01-1.32%$1.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier